Opinion
Video
Future Perspectives in the Treatment of Polycythemia Vera
John Mascarenhas, MD, and Joe Scandura, MD, PhD, close their discussion by highlighting what to look forward to in the future of polycythemia vera treatment.
EP: 1.Risk Assessment in Patients With Polycythemia Vera (PV)
EP: 2.Reducing Risk of Disease Progression in Patients With PV
EP: 3.Typical Presentation of a Patient With PV
EP: 4.Importance of Bone Marrow Biopsy For Diagnosis of PV
EP: 5.Reducing Risk of Thrombosis in Patients With PV
EP: 6.Factoring Symptom Burden Into Treatment Decision-Making for Patients With PV
EP: 7.Managing Toxicities of Hydroxyurea in Patients With PV
EP: 8.Managing Toxicities of Ropeginterferon Alpha-2b in Patients With PV
EP: 9.Key Trials in the Treatment of PV
EP: 10.Treatment Approaches for High-Risk Patients With PV
EP: 11.Influence of Driver Mutations on Response to Ropeginterferon Alpha-2b in Patients with PV
EP: 12.Ruxolitinib in the Treatment of PV
Now Viewing
EP: 13.Future Perspectives in the Treatment of Polycythemia Vera
Related Videos
Related Content
